Petra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Petra and buy or sell other stocks, ETFs, and their options commission-free!About PAIC
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity.
CEOJames M. Rolke
CEOJames M. Rolke
Employees9
Employees9
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2019
Founded2019
Employees9
Employees9
PAIC Key Statistics
Market cap2.73M
Market cap2.73M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume134.80K
Average volume134.80K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$60.48
52 Week high$60.48
52 Week low$0.8301
52 Week low$0.8301
Stock Snapshot
The current Petra(PAIC) stock price is $0.76, with a market capitalization of 2.73M. The stock trades at a price-to-earnings (P/E) ratio of -0.03.
On 2025-12-21, Petra(PAIC) stock opened at —, reached a high of —, and a low of —.
The Petra(PAIC)'s current trading volume is 0, compared to an average daily volume of 134.8K.
During the past year, Petra(PAIC) stock moved between $0.83 at its lowest and $60.48 at its peak.
During the past year, Petra(PAIC) stock moved between $0.83 at its lowest and $60.48 at its peak.
People also own
Based on the portfolios of people who own PAIC. This list is generated using Robinhood data, and it’s not a recommendation.